SRPT — Sarepta Therapeutics
Median target
$20
calls from the last 12 months
Implied return
-3.2%
median target vs. price
Coverage
21 analysts · 23 calls
updated in the last 12 months
Consensus
6/11/4+2 net
Buy / Hold / Sell
Which analysts are behind SRPT's consensus?
See every current rating, price target and the analysts' track records for Sarepta Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 21 analysts with calls on SRPT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
SRPT elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-03-30 | Executive | Trump, Donald JPresident | Sale | Sarepta Therapeutics, Inc. | $1,001 - $15,000 |
| 2025-09-02 | Executive | Trump, Donald JPresident | Purchase | SAREPTA THERAPEUTICS INC | $15,001 - $500,009 |
| 2025-05-12 | Executive | Trump, Donald JPresident | Sale | SAREPTA THERAPEUTICS INC | $1,001 - $150,005 |
| 2025-04-11 | Executive | Trump, Donald JPresident | Purchase | SAREPTA THERAPEUTICS INC | $1,001 - $150,004 |
| 2025-03-10 | Executive | Trump, Donald JPresident | Sale | SAREPTA THERAPEUTICS INC | $1,001 - $150,003 |
| 2023-07-14 | Congress | Josh GottheimerNJ-NJ05 | Purchase | since trade -81.4%, vs market -156.9% | $1K–$15K |
| 2023-06-13 | Congress | Josh GottheimerNJ-NJ05 | Sale | since trade -84.5%, vs market +165.8% | $1K–$15K |
| 2023-04-10 | Congress | Daniel GoldmanNY-NY10 | Sale | since trade -85.7%, vs market +178.9% | $15K–$50K |
| 2023-03-06 | Congress | Daniel GoldmanNY-NY10 | Purchase | since trade -87.1%, vs market -183.5% | $15K–$50K |
| 2023-03-06 | Congress | Josh GottheimerNJ-NJ05 | Purchase | since trade -87.1%, vs market -183.5% | $1K–$15K |
More: congressional trades on SRPT · insider activity · executive branch · trending